BlackRock Health Sciences Tr (XBMEX): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders of XBMEX (all 13F filers)
- Morgan Stanley365 KBank or trading desk+6,827
- Bank of America275 KBank or trading desk+8,870
- 1607 Capital Partners164 KType not verified−70 K
- Wells Fargo160 KBank or trading desk+6,897
- Royal Bank of Canada155 KBank or trading desk−5,806
- Nova R Wealth141 KWealth adviser−14 K
- Karpus Management140 KType not verified−1,104
- Invesco130 KInvestment firm−4,569
- LPL Financial113 KWealth adviser+5,367
- Raymond James Financial110 KWealth adviser+2,375
- Shares
- 365 K
- Change
- +6,827
See more
- Type
- Bank or trading desk
- Value
- $15.7M
- Shares
- 275 K
- Change
- +8,870
See more
- Type
- Bank or trading desk
- Value
- $11.8M
- Shares
- 164 K
- Change
- −70 K
See more
- Type
- Type not verified
- Value
- $7.0M
- Shares
- 160 K
- Change
- +6,897
See more
- Type
- Bank or trading desk
- Value
- $6.9M
- Shares
- 155 K
- Change
- −5,806
See more
- Type
- Bank or trading desk
- Value
- $6.7M
- Nova R Wealth
- Shares
- 141 K
- Change
- −14 K
See more
- Type
- Wealth adviser
- Value
- $6.1M
- Shares
- 140 K
- Change
- −1,104
See more
- Type
- Type not verified
- Value
- $6.0M
- Shares
- 130 K
- Change
- −4,569
See more
- Type
- Investment firm
- Value
- $5.6M
- Shares
- 113 K
- Change
- +5,367
See more
- Type
- Wealth adviser
- Value
- $4.9M
- Shares
- 110 K
- Change
- +2,375
See more
- Type
- Wealth adviser
- Value
- $4.7M
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
This list may be incomplete: we hold 13D and 13G filings made since December 2024. A holder above 5% that has not filed anything since then is not shown here.
No recent filings.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗